WebThe anticancer agent, irinotecan, is a prodrug that is converted by tissue carboxylesterase to 7-ethyl-10-hydroxycamptothecin (SN-38), a potent inhibitor of DNA topoisomerase I. Its action is terminated by glucuronidation by UDP glucuronosyl transferase. Safety Information Pictograms GHS07 Signal Word Warning Hazard Statements H302 Irinotecan is a topoisomerase inhibitor —it blocks the topoisomerase I enzyme, resulting in DNA damage and cell death. ... The molecular action of irinotecan occurs by trapping a subset of topoisomerase-1-DNA cleavage complexes, those with a guanine +1 in the DNA sequence. See more Irinotecan, sold under the brand name Camptosar among others, is a medication used to treat colon cancer, and small cell lung cancer. For colon cancer it is used either alone or with fluorouracil. For small cell lung cancer it is … See more Its main use is in colon cancer, in particular, in combination with other chemotherapy agents. This includes the regimen See more Camptothecin, one of the four major structural classifications of plant-derived anti-cancerous compounds, is a cytotoxic alkaloid which … See more Irinotecan is converted by an enzyme into its active metabolite SN-38, which is in turn inactivated by the enzyme UGT1A1 by glucuronidation. See more The most significant adverse effects of irinotecan include diarrhea, nausea and vomiting, neutropenia and fever, infections of blood or lungs (sepsis, pneumonia), shock, dehydration, kidney failure and thrombocytopenia (low levels of blood platelets). See more Administration Irinotecan can be administrated by 30- or 90-minute intravenous infusions of either 125 mg/m weekly for four of every six weeks or 350 mg/m … See more Irinotecan received accelerated approval from the U.S. Food and Drug Administration (FDA) in 1996, and full approval in 1998. Names See more
Irinotecan Therapy and UGT1A1 Genotype - Medical Genetics …
WebTopoisomerase I Inhibitors Name Topoisomerase I Inhibitors Accession Number DBCAT001116 Description Compounds that inhibit the activity of DNA TOPOISOMERASE I. Drugs Drugs & Drug Targets WebDec 1, 1997 · Abstract. Topoisomerase I inhibitors are a new class of anticancer agents with a mechanism of action aimed at interrupting DNA replication in cancer cells, the result of … jello with cream cheese fruit
Irinotecan Autophagy Topoisomerase TargetMol
WebJan 4, 2001 · Irinotecan is a water soluble, topoisomerase-1 inhibitor derived from a plant alkaloid, which results in single stranded breaks in DNA and inhibition of DNA repair enzymes leading to interference with DNA synthesis. 7 Irinotecan has been approved by the Food and Drug Administration for metastatic colorectal cancer in the USA, but also has … WebTopoisomerase (TOP) inhibitors are chemotherapeutic drugs that cause DNA double-strand breaks during DNA replication. These can be repaired by homologous recombination, but some tumors, such as triple-negative breast cancer, have defects in … WebAug 17, 2024 · BAY 1895344 Plus Topoisomerase-1 (Top1) Inhibitors in Patients With Advanced Solid Tumors, Phase I Studies With Expansion Cohorts in Small Cell Lung … oz tv show theme song